Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel potent TGR5 agonist shows antidiabetic effects in TGR5(H88Y) mutant mice

Sep. 17, 2021

Nanjing Sanhome Pharmaceutical divulges anti-CD47/anti-PD-L1 antibodies

Sep. 17, 2021

Achillion Pharmaceuticals identifies new complement factor D inhibitors

Sep. 17, 2021

UCL Business describes new CRP inhibitors

Sep. 17, 2021

Bahcesehir Universitesi presents Hdm2 inhibitors

Sep. 17, 2021

Guanylate cyclase C agonist IW-3300 shows promise for treating visceral pain

Sep. 17, 2021

Mitokinin discloses PINK1 activators

Sep. 17, 2021

CNGA1 behind retinal degeneration, murine model shows

Sep. 17, 2021

KRAS just wants to help: Pancreatic KRAS mutations may be protection gone bad

Sep. 17, 2021

Blood-to-brain pathway may deliver amyloids in Alzheimer's disease

Sep. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...